SAN DIEGO, Nov. 2, 2012 /PRNewswire/ -- Today, 1 in 3 adults have reﬂux symptoms monthly and it is estimated that over 50 million adults have symptoms several times each week. To help these individuals, ReﬂuxMD, Inc. (www.refluxmd.com) ofﬁcially launched its services today taking action to ﬁght the growing incidence of reﬂux disease in the United States through knowledge, community, and innovative online tools for consumers.
"Despite spending over $15 billion annually on prescription and over-the-counter medications, the incidence of reﬂux disease and the serious complications that may result are growing at a rate of 30% each decade," said Bruce Kaechele, CEO and founder of ReﬂuxMD. "The status quo approach to the diagnosis and treatment of reﬂux disease is expensive and ineffective as we rapidly approach epidemic levels."
The cost to employers is enormous. Studies have found that individuals suffering from reﬂux disease, also know as GERD, cost employers approximately $3,355 more annually than employees without reﬂux disease. In addition, a study by the American College of Gastroenterology found that the cost to employers from absenteeism and lost productivity due to reﬂux disease was $1.9 billion each week, or almost $100 billion annually.
ReﬂuxMD is the only comprehensive online service designed for consumers exclusively focused on reﬂux disease. On its website the company offers a variety of innovative tools to enable sufferers to understand, manage, and halt the progression of their disease. The most unique of these tools are:
- Interactive online reﬂux disease assessment;
- Online application allowing members to ask a conﬁdential question to a reﬂux expert;
- Screened and vetted expert physicians available to connect with members, and;
- Online priority scheduling of appointments with ReﬂuxMD's participating physicians.
ReﬂuxMD's platform was designed with three leading reﬂux disease clinical experts: Dr. Tom DeMeester, Dr. Para Chandrasoma, and Dr. William Dengler. Drs. DeMeester and Chandrasoma are both internationally recognized as thought leaders in reﬂux disease, and Dr. Dengler, also an acknowledged GERD expert, has assisted hospitals and physician groups to establish comprehensive Heartburn Treatment Centers. This collective knowledge and clinical practice expertise has culminated in the development of the Pasadena Protocol, a new set of conventions, principals, and behaviors that have the power to dramatically impact the treatment of reﬂux disease.
About ReﬂuxMD, Inc.
ReﬂuxMD (www.refluxmd.com) is a San Diego, CA -based Internet healthcare company focused on gastroesophageal reﬂux disease, offering sufferers a complete personalized reﬂux resource. Working with physicians, employers and healthcare payers, ReﬂuxMD will drive higher patient satisfaction, improved medical outcomes, and lower healthcare costs.
CONTACT: Bruce Kaechele
This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.